Cargando…

Intestinal Microbiota in Elderly Inpatients with Clostridioides difficile Infection

PURPOSE: The incidence of Clostridioides difficile infection (CDI) has been reported as 10-fold higher among the elderly population than in young adults. The aim of this study was to compare the targeted bacteria population in the fecal microbiota in two groups of hospitalized elderly, categorized a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vakili, Bahareh, Fateh, Abolfazl, Asadzadeh Aghdaei, Hamid, Sotoodehnejadnematalahi, Fattah, Siadat, Seyed Davar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415437/ https://www.ncbi.nlm.nih.gov/pubmed/32801806 http://dx.doi.org/10.2147/IDR.S262019

Ejemplares similares

Effects of active, inactive, and derivatives of Akkermansia muciniphila on the expression of the endocannabinoid system and PPARs genes
por: Ghaderi, Farinaz, et al.
Publicado: (2022)

Author Correction: Effects of active, inactive, and derivatives of Akkermansia muciniphila on the expression of the endocannabinoid system and PPARs genes
por: Ghaderi, Farinaz, et al.
Publicado: (2022)

Curcumin and capsaicin regulate apoptosis and alleviate intestinal inflammation induced by Clostridioides difficile in vitro
por: Azimirad, Masoumeh, et al.
Publicado: (2022)

Intestinal microbiota changes pre- and post-fecal microbiota transplantation for treatment of recurrent Clostridioides difficile infection among Iranian patients with concurrent inflammatory bowel disease
por: Gholam-Mostafaei, Fahimeh Sadat, et al.
Publicado: (2023)

Emerging applications of phage therapy and fecal virome transplantation for treatment of Clostridioides difficile infection: challenges and perspectives
por: Raeisi, Hamideh, et al.
Publicado: (2023)

Treatment of Recurrent Clostridioides difficile Infection Using Fecal Microbiota Transplantation in Iranian Patients with Underlying Inflammatory Bowel Disease
por: Azimirad, Masoumeh, et al.
Publicado: (2020)

Application of recombinant antibodies for treatment of Clostridioides difficile infection: Current status and future perspective
por: Raeisi, Hamideh, et al.
Publicado: (2022)

Rapid-format recombinant antibody-based methods for the diagnosis of Clostridioides difficile infection: Recent advances and perspectives
por: Raeisi, Hamideh, et al.
Publicado: (2022)

Nontuberculous Mycobacterial Resistance to Antibiotics and Disinfectants: Challenges Still Ahead
por: Tarashi, Samira, et al.
Publicado: (2022)

From the Role of Microbiota in Gut-Lung Axis to SARS-CoV-2 Pathogenesis
por: Ahmadi Badi, Sara, et al.
Publicado: (2021)

Alterations and Prediction of Functional Profiles of Gut Microbiota After Fecal Microbiota Transplantation for Iranian Recurrent Clostridioides difficile Infection with Underlying Inflammatory Bowel Disease: A Pilot Study
por: Azimirad, Masoumeh, et al.
Publicado: (2022)

Serum procalcitonin levels associate with Clostridioides difficile infection in patients with inflammatory bowel disease
por: Abdehagh, Mohammad, et al.
Publicado: (2021)

How Does COVID-19 Pandemic Impact on Incidence of Clostridioides difficile Infection and Exacerbation of Its Gastrointestinal Symptoms?
por: Azimirad, Masoumeh, et al.
Publicado: (2021)

Microbiota-Derived Extracellular Vesicles as New Systemic Regulators
por: Ahmadi Badi, Sara, et al.
Publicado: (2017)

New insights of Helicobacter pylori host-pathogen interactions: The triangle of virulence factors, epigenetic modifications and non-coding RNAs
por: Vaziri, Farzam, et al.
Publicado: (2018)

Development and characterization of phage display-derived anti-toxin antibodies neutralizing TcdA and TcdB of Clostridioides difficile
por: Raeisi, Hamideh, et al.
Publicado: (2023)

Pulmonary Infection Related to Mimivirus in Patient with Primary Ciliary Dyskinesia
por: Sakhaee, Fatemeh, et al.
Publicado: (2020)

Reactivation of Mycobacterium simiae after the recovery of COVID-19 infection
por: Masoumi, Morteza, et al.
Publicado: (2021)

A case report of wrist synovial infection due to Mycobacterium jacuzzii, Iran
por: Sakhaee, Fatemeh, et al.
Publicado: (2020)

Analysis of Intestinal Mycobiota of Patients with Clostridioides difficile Infection among a Prospective Inpatient Cohort
por: Cao, Yangchun, et al.
Publicado: (2022)

Gut microbiota and microbiota-based therapies for Clostridioides difficile infection
por: Chopra, Teena, et al.
Publicado: (2023)

Pulmonary Infection Associated with Mycobacterium canariasense in Suspected Tuberculosis Patient, Iran
por: Sakhaee, Fatemeh, et al.
Publicado: (2019)

Fecal microbiota transplantation beyond Clostridioides difficile infections
por: Wortelboer, Koen, et al.
Publicado: (2019)

Fecal Microbiota Transplantation beyond Clostridioides Difficile Infection
por: Moon, Chang Mo, et al.
Publicado: (2021)

54101 Characterizing Microbiota Features of Clostridioides difficile Infections
por: Tomkovich, Sarah, et al.
Publicado: (2021)

Enhancing the differentiation of specific genotypes in Mycobacterium tuberculosis population
por: Hadifar, Shima, et al.
Publicado: (2019)

Investigation of Intestinal Microbiota and Fecal Calprotectin in Non-Toxigenic and Toxigenic Clostridioides difficile Colonization and Infection
por: Han, Sung-Hee, et al.
Publicado: (2020)

Epigallocatechin-3-Gallate Improves Intestinal Gut Microbiota Homeostasis and Ameliorates Clostridioides difficile Infection
por: Wu, Zhengjie, et al.
Publicado: (2022)

Variation in Mycobacterium tuberculosis population structure in Iran: a systemic review and meta-analysis
por: Hadifar, Shima, et al.
Publicado: (2021)

Tuberculosis prevention, diagnosis, and treatment financial profile during 2006–2021: PART A
por: Meskini, Maryam, et al.
Publicado: (2023)

Insights into the Role of Human Gut Microbiota in Clostridioides difficile Infection
por: Kachrimanidou, Melina, et al.
Publicado: (2020)

Microbiota-based markers predictive of development of Clostridioides difficile infection
por: Berkell, Matilda, et al.
Publicado: (2021)

Gut Microbiota Composition Associated with Clostridioides difficile Colonization and Infection
por: Martinez, Elisa, et al.
Publicado: (2022)

Fecal Microbiota of Toxigenic Clostridioides difficile-Associated Diarrhea
por: Hernández, Marta, et al.
Publicado: (2019)

Microbial ecology between Clostridioides difficile and gut microbiota
por: KAMIYA, Shigeru
Publicado: (2023)

Diagnostic Methods of Clostridioides difficile Infection and Clostridioides difficile Ribotypes in Studied Sample
por: Novakova, Elena, et al.
Publicado: (2021)

Clostridioides difficile ribotypes 001 and 126 were predominant in Tehran healthcare settings from 2004 to 2018: a 14-year-long cross-sectional study
por: Azimirad, Masoumeh, et al.
Publicado: (2020)

Molecular epidemiology of nontuberculous mycobacteria isolated from tuberculosis-suspected patients
por: Tarashi, Samira, et al.
Publicado: (2023)

Reductions in Postdischarge Clostridioides difficile Infection after an Inpatient Health System Fluoroquinolone Stewardship
por: Ashley Jones, K., et al.
Publicado: (2021)

Fecal microbiota transplantation for COVID-19; a potential emerging treatment strategy
por: Nejadghaderi, Seyed Aria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ss45bjgpha4kda3kkio22ungvd